Get started
Author

Kevin Imrie

Observed names: K Imrie, K R Imrie, K. Imrie, K. R. Imrie, Kevin L. Imrie, Kevin R Imrie, Kevin R. Imrie, Kevin Robert Imrie
Observed institutions: Medical University of Lublin, Mount Sinai Hospital, Dalhousie University, Sunnybrook Health Science Centre, University Health Network, University of Toronto, Cancer Care Ontario, Juravinski Cancer Centre, Queen Elizabeth II Health Sciences Centre, Ottawa Hospital, Kingston General Hospital, London Health Sciences Centre, Monash Medical Centre, Juravinski Hospital, Princess Margaret Cancer Centre, CancerCare Manitoba, Hôpital Charles-Le Moyne, Victoria Hospital, Royal Marsden Hospital, Addenbrooke's Hospital, Sunnybrook Hospital, Cross Cancer Institute, Canadian Cancer Trials Group, Odette Cancer Centre, McGill University, Hamilton Health Sciences, Royal College of Physicians and Surgeons of Canada, McMaster University
OpenAlex ID: A5032098740
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
2006 · Michael Pfreundschuh, Lorenz Trümper, et al. · The Lancet Oncology · 2,077
Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
2008 · Robert Marcus, Kevin Imrie, et al. · Journal of Clinical Oncology · 594
A Systematic Review of the Effects of Resident Duty Hour Restrictions in Surgery
2014 · Najma Ahmed, Katharine S. Devitt, et al. · Annals of Surgery · 514
Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
2014 · Michael Crump, John Kuruvilla, et al. · Journal of Clinical Oncology · 462
PDF
Isolated Chloroma: The Effect of Early Antileukemic Therapy
1995 · Kevin R. Imrie, Michael J. Kovacs, et al. · Annals of Internal Medicine · 216
Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
2003 · T. Baetz, A. Belch, et al. · Annals of Oncology · 161
PDF
Bortezomib in Multiple Myeloma: Systematic Review and Clinical Considerations
2014 · T.C. Kouroukis, F.G. Baldassarre, et al. · Current Oncology · 127
PDF
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphoma
2004 · Michael Crump, Tara Baetz, et al. · Cancer · 126
Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis
2004 · J. Mangel, H.A. Leitch, et al. · Annals of Oncology · 99
Ovarian function after autologous bone marrow transplantation.
1998 · A D Schimmer, M Quatermain, et al. · Journal of Clinical Oncology · 87
Impact of central nervous system ( CNS ) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B ‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
2012 · Hany R. Guirguis, Matthew C. Cheung, et al. · British Journal of Haematology · 85
PDF
A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma
2008 · Lisa K. Hicks, Adam E. Haynes, et al. · Cancer Treatment Reviews · 73
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma
2008 · L K Hicks, A Woods, et al. · Bone Marrow Transplantation · 71
Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections
1996 · H. Miles Prince, Kevin Imrie, et al. · British Journal of Haematology · 71
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
1999 · R Buckstein, K Imrie, et al. · PubMed · 69
First Analysis of the Completed Mabthera International (Mint) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease.
2004 · Michael Pfreundschuh, Lorenz Truemper, et al. · Blood · 61
Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario
2007 · Matthew C. Cheung, Adam E. Haynes, et al. · Cancer Treatment Reviews · 58
Microbial contamination of harvested bone marrow and peripheral blood.
1995 · H M Prince, S R Page, et al. · PubMed · 58
Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
2003 · Elena Gitelson, Caitlin Hammond, et al. · PubMed · 53
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
2002 · Joy Mangel, Rena Buckstein, et al. · Seminars in Oncology · 53
Resident duty hours: past, present, and future
2014 · Kevin R Imrie, Jason R Frank, et al. · BMC Medical Education · 44
PDF
Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
1995 · A K Stewart, K Imrie, et al. · PubMed · 44
Alemtuzumab in Chronic Lymphocytic Leukemia
2007 · G. Fraser, C.A. Smith, et al. · Current Oncology · 41
PDF
The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative
2002 · Kevin Imrie, Rosmin Esmail, et al. · Annals of Internal Medicine · 40
Core Competencies or a Competent Core? A Scoping Review and Realist Synthesis of Invasive Bedside Procedural Skills Training in Internal Medicine
2017 · Ryan Brydges, Lynfa Stroud, et al. · Academic Medicine · 39
PDF
Works count: 129
Citation count: 6,215
H-index: 33
I10-index: 58
Year
Topic
Type